high sensitivity C-reactive protein

high sensitivity C-reactive protein

Lab medicine A method of measuring CRP, with higher sensitivity; HSCRP identifies Pts at risk for stroke, cardiovascular and peripheral vascular disease. See C-reactive protein.
References in periodicals archive ?
Nutritional states were evaluated by the measurements of body weight, body composition, and muscle strength, and the nutritional hematological examination results (retinol-binding protein (RBP), prealbumin (PA), transferrin (Tf), and hemoglobin (Hb) in serum), and inflammation biomarkers such as carboxyhemoglobin (COHb), High sensitivity C-reactive protein (Hs-CRP), Tumor Necrosis Factor-alpha (TNF-[alpha]), Interleukin 6 (IL-6), and Serum Amyloid A (SAA) were measured.
Evaluation of serum high sensitivity C-reactive protein (hs-CRP) in Type-2 diabetic patient.
Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
Clinical Significance of serial determination of serum high sensitivity C-reactive protein (hs-CRP) levels in neonatal infection.
In Mexican healthy children, the high sensitivity C-reactive protein (hsCRP) median was of 0.3 mg/L and it was positively and significantly correlated with BMI and LDL-C (14).
To study the significance of high sensitivity C-reactive protein as a biochemical marker in metabolic syndrome.
High sensitivity C-reactive protein (hs-CRP) is considered as one of the basic systemic inflammatory biomarkers and has a key role in the development of coronary heart disease alone and in type 2 diabetes mellitus.
Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer.
These biomarkers include high sensitivity C-reactive protein (CRP), fibrin degradation products (FDP) and heat shock protein 70 (HSP70).
High sensitivity C-reactive protein in subjects with type diabetes mellitus and/or high blood pressure.
In a recent study, low levels of vitamin C were associated with higher levels of high sensitivity C-reactive protein (hsCRP) and shorter intervals without major cardiac problems or death for heart failure patients.
A prospective study of high sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study 1984 to 1998.